Renovascular disease (RVD) is the most common potentially reversible cause of hypertension and renal failure in the US. Anatomic studies such as x-ray angiography are invasive, use nephrotoxic contrast agents, and do not accurately predict response to revascularization. Functional studies, such as angiotensin-converting enzyme (ACE) inhibitor (captopril) radionuclide renography, can predict response to revascularization, but do not provide important anatomic information for treatment planning. The lack of an accurate diagnostic test has also precluded definitive evaluation of optimal treatment strategies for RVD. Magnetic resonance (MR) imaging offers the unique potential to combine anatomic evaluation about RAS with functional information about renal ischemia and dysfunction in a single clinical examination. Broad, long-term objectives: To reduce the morbidity and mortality associated with hypertension and renal failure due to RVD by correctly diagnosing the disease and by determining which patients are likely to benefit from revascularization therapy and which patients should be treated with medication alone.
Specific Aims /Methods: (1) To validate ultra-low dose 3D Gd-DTPA MR renography combined with T1 mapping for the measurement of single kidney GFR and other tracer kinetic parameters as compared with conventional nuclear medicine renography using 99mTc-DTPA. Development and testing of a newly developed automated registration and semiautomated segmentation algorithm will also be completed. (2) To evaluate prospectively the accuracy of MRA combined with ACE-inhibitor MR renography, performed in a single exam, for the diagnosis of RVD, using hypertension and creatinine clearance as measures of response, as well as improvements in single kidney function (see Aim 3). A multi-compartmental tracer kinetic model will also be applied to renography results to identify more sensitive predictors of response to therapy. (3) To conduct a longitudinal study using MR renography to measure response to revascularization in terms of improvements in single kidney function as compared to global kidney function or creatinine clearance. At its conclusion, our study has a high likelihood of showing that the combination of MRA and MR renography, by uniquely providing both anatomic and functional information in a single examination, will accurately diagnose RVD and provide a comprehensive tool for measuring outcomes following therapy.
Hofstetter, Lorne W; Morrell, Glen; Kaggie, Joshua et al. (2017) T2* Measurement bias due to concomitant gradient fields. Magn Reson Med 77:1562-1572 |
Morrell, Glen R; Zhang, Jeff L; Lee, Vivian S (2017) Magnetic Resonance Imaging of the Fibrotic Kidney. J Am Soc Nephrol 28:2564-2570 |
Xie, Luke; Layton, Anita T; Wang, Nian et al. (2016) Dynamic contrast-enhanced quantitative susceptibility mapping with ultrashort echo time MRI for evaluating renal function. Am J Physiol Renal Physiol 310:F174-82 |
Zhang, Jeff L; Morrell, Glen; Rusinek, Henry et al. (2014) Measurement of renal tissue oxygenation with blood oxygen level-dependent MRI and oxygen transit modeling. Am J Physiol Renal Physiol 306:F579-87 |
Zhang, Jeff L; Morrell, Glen; Rusinek, Henry et al. (2014) New magnetic resonance imaging methods in nephrology. Kidney Int 85:768-78 |
Kang, Stella K; Huang, William C; Lee, Vivian S et al. (2013) MR renographic measurement of renal function in patients undergoing partial nephrectomy. AJR Am J Roentgenol 200:1204-9 |
Kang, Stella K; Huang, William C; Wong, Samson et al. (2013) Dynamic contrast-enhanced magnetic resonance imaging measurement of renal function in patients undergoing partial nephrectomy: preliminary experience. Invest Radiol 48:687-92 |
Vivier, Pierre-Hugues; Storey, Pippa; Chandarana, Hersh et al. (2013) Renal blood oxygenation level-dependent imaging: contribution of R2 to R2* values. Invest Radiol 48:501-8 |
Zhang, Jeff L; Rusinek, Henry; Chandarana, Hersh et al. (2013) Functional MRI of the kidneys. J Magn Reson Imaging 37:282-93 |
Zhang, Jeff L; Morrell, Glen R; Lee, Vivian S (2013) Blood oxygen level-dependent MR in renal disease: moving toward clinical utility. Radiology 268:619-21 |
Showing the most recent 10 out of 25 publications